Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center, Randomized, Active-controlled, Double-blinded (to Subject and Investigator), Non-inferiority Study of Single Intra-articular Injection of 2107 Injection in Subjects With Mild to Moderate Knee Osteoarthritis

NCT07746843 is registered in ClinicalTrials.gov with BioRegen Biomedical (Changzhou) Co., Ltd as lead sponsor.

NCT NCT07746843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07746843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center, Randomized, Active-controlled, Double-blinded (to Subject and Investigator), Non-inferiority Study of Single Intra-articular Injection of 2107 Injection in Subjects With Mild to Moderate Knee Osteoarthritis
Lead sponsor
BioRegen Biomedical (Changzhou) Co., Ltd
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
December 31, 2028
Enrollment
286 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mild knee osteoarthritis, moderate knee osteoarthritis